Steven A. Shallcross, CEO and CFO: Theriva Biologics TOVX Buy · Filed 23/01/23

Trade details

Type: Insider buy
Amount: $18,750
Shares · price: 25,000 sh · $0.75 a share
Held after: 135,000 sh
Stock: Theriva Biologics TOVX
Person: Steven A. ShallcrossCEO and CFO
Trade date: 23/01/20
Filed: 23/01/23
Days to filing: 3 days

Holdings up 22.7%

Insiders buying this week: 1 insiders
Holding change: +22.7%

Theriva Biologics trades, last 26 weeks

What else happened in Theriva Biologics around then

Filed or reported within 30 days of the trade day · 22/12/21~23/02/19

Steven A. Shallcross's recent trades

Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$9,660
14,000 sh
$9,660
Filed 23/06/08
Traded 23/06/07
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$16.4K
26,000 sh
$16.4K
Filed 23/06/07
Traded 23/06/06
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$26K
25,000 sh
$26K
Filed 23/02/13
Traded 23/02/10
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$23.5K
25,000 sh
$23.5K
Filed 23/02/03
Traded 23/02/02
Steven A. ShallcrossCEO and CFO
BuyTheriva Biologics
Buy
Theriva Biologics
TOVX
$21.8K
25,000 sh
$21.8K
Filed 23/01/26
Traded 23/01/25